The results showed that the tumors in the group injected with HCT116 cells with stable KIF4A knockdown exhibited significantly lesser tumor growth capacity (Fig. 8b) and smaller tumor volumes (Fig. 8c) than the control group. This evidence concerns the gene KIF4A and neoplasm.